Company insight
efficient digitalised clinical care pathways. It should be considered that solutions might need to extend beyond the hospital’s boundaries, encompassing outpatient care and various stakeholders, like laboratories, standalone practices, remote experts and the patient themselves to be able to support the patient journey.
How can these companies benefit from working with ZEISS Digital Innovation?
Drawing from our first-hand experience with clients across the ZEISS Group and our network of partners in healthcare, science, and technology, we understand the critical success factors in the industry. This knowledge enables us to accelerate the development of digital health innovations for all our clients. That means we support our clients end- to-end in realising their ambitious software development projects; we know the typical challenges, regulations, standards and technologies of the industry. We are able to develop future proof software as a medical device (SaMD) products and modern embedded software for medical devices
efficiently, helping our clients to bring their innovative products to the market fast and successfully.
Can you give a real-world example to illustrate the value of investing in digitalisation to enhance a MedTech product? Certainly. Digital care pathways have been shown to have a significant positive impact on efficiencies and quality in resource- intense areas, like operating rooms. Several studies and articles have demonstrated real-world impact in hospitals. For example, a systematic review by Schudnat et al. (2023) found in 5 out of 22 articles that digitalisation and standardisation led to a reduction in OR-time of 6–22% per case, resulting in significant positive impact on efficiency and quality. We also see such results with the clients we work with – the benefits of the digitalisation of care processes can definitely be seen in the real world already.
Do you see this kind of digitalised care pathways becoming more common in the future, and care
We Speak Health & Digital: Jointly Deliver to Accelerate your Digital MedTech and Diagnostic Innovations.
becoming more data-driven? I think this debate is already over: I have noticed a strong consensus within the healthcare industry that there must be a shift towards prevention and treatment supported by digital technology to improve patient outcomes and efficiency. This transformation is already underway, with widespread recognition that digitalised care pathways are essential for effective prevention and treatment. While not every MedTech company is in the position to provide workflows for specific diseases or treatments, a considerable number are well-positioned to do so. However, every MedTech company should actively consider how they can integrate their products into a care pathway, either independently or in collaboration with other vendors. Leveraging the potential of software solutions is key to ensuring the longevity and relevance of their product portfolios in the ever-advancing landscape of healthcare. As such, the shift towards a digitalised care pathway is not just a future possibility; it’s a present necessity. ●
www.zeiss.ly/healthsoftwareservices
Carl Zeiss Digital Innovation GmbH
Your custom Health Software Development and Quality Assurance Partner for medtech and diagnostics. We design, build, test, and operate your solutions.
zeiss.ly/healthsoftwareservices Address your digital health
challenge with us:
Medical Device Developments /
www.nsmedicaldevices.com
65
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136
